Safety Information for EPI-GUIDE
The EASEE® System is an active implantable Class III medical device, approved for the EU market and additional markets (CE marking since September 2022), indicated for adults with drug-resistant focal epilepsy in whom at least two appropriate antiseizure medications have failed to achieve adequate seizure control.
The implantation may only be performed by specially trained physicians in appropriately qualified centers. Individual suitability is determined by your treating physicians.
The information provided by the EPI-GUIDE service is for general orientation purposes only. It does not replace medical examination, diagnosis, or consultation. All treatment decisions are made jointly with your treating physicians.
As with any implantable medical device, potential risks exist. A complete list of risks, contraindications, and safety information is provided in the instructions for use of the EASEE® system or should be discussed with your treating physicians.
The EASEE® System is MRI-compatible under specific conditions. Prior to any MRI scan, please inform the radiology team about your implant and share the MRI guidelines.
Clinical studies have shown the efficacy of EASEE®. Individual treatment outcomes may vary.
In a medical emergency, please call your local emergency number immediately (e.g., 112, 911, or 999)